WBD Rejects Paramount Bid, Amazon in Talks to Invest $10B in OpenAI
The Rundown
00:00
DBV's Peanut Patch Trial Win
Zaid reports DBV Technologies' positive phase three results and plans to file for FDA biologics license in 2026.
Play episode from 06:15
Transcript
